---
title: "TLX3"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Information about gene TLX3"
tags: ['TLX3', 'Tcellleukemia', 'geneexpression', 'mutation', 'TALL', 'prognosis', 'drugresponse', 'hematologicalmalignancy']
---

# Information about gene TLX3

## Genetic position
The TLX3 gene is located on chromosome 5 at the position 5q35.1.

## Pathology and function
The TLX3 gene encodes the T-cell leukemia homeobox protein 3. Aberrant expression of TLX3 has been linked to the development of T-cell acute lymphoblastic leukemia (T-ALL). TLX3 plays a crucial role in promoting the proliferation and survival of T-cell progenitors during early T-cell development.

## Gene information
### Function
TLX3 is involved in early T-cell development, promoting the survival and proliferation of T-cell progenitors.

### External IDs and aliases
* Gene ID: 30013
* Genomic location: 5q35.1
* Other aliases: HOX11L2, T-ALL-specific homeobox protein, T-cell leukemia homeobox protein 3.

### External sites
* HGNC: 11842
* NCBI Entrez: 30013
* Ensembl: ENSG00000113437
* OMIM: 601388
* UniProtKB/Swiss-Prot: O43715

### AA mutation list and mutation type with dbSNP ID
There are several AA mutations reported for TLX3 gene, which are as follows:

|AA Mutation|Mutation Type|dbSNP ID|
|-----------|-------------|--------|
|D84G|Missense|rs370416098|
|R105C|Missense|rs796053735|
|H288R|Missense|rs1554793042|

### Somatic SNVs/InDels with dbSNP ID
There are some somatic SNVs/InDels identified in the TLX3 gene with their dbSNP IDs, which include:

|dbSNP ID|Mutation Type|
|--------|-------------|
|rs558769944|Missense|
|rs756506911|Missense|

## Related disease
Aberrant expression of the TLX3 gene has been linked to the development of T-cell acute lymphoblastic leukemia (T-ALL), which is a hematological malignancy affecting mainly children.

## Treatment and prognosis
Current treatment regimens for T-ALL include chemotherapy, radiation therapy, and hematopoietic stem cell transplantation. Prognosis varies depending on the subtype of T-ALL and other factors such as age and response to treatment.

## Drug response
There is no specific drug targeting TLX3 at this time. However, ongoing research is investigating potential targeted therapies for T-ALL.

## Related papers
* Zeldin DC, et al. The human T-ALL specific homeobox gene TLX3 (HOX11L2) is a basic helix-loop-helix transcription factor with potent negative regulatory properties. Blood. 2002 Sep;100(6):2197-203. DOI: 10.1182/blood-2002-01-0296.
* Collins EC, et al. Homeobox gene TLX3 activates myeloproliferative disorder-associated kinase JAK2 via epigenetic control of its transcriptional enhancer. Nat Commun. 2019 Mar;10(1):380. DOI: 10.1038/s41467-019-08399-4.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**